A logistic regression model based on the national mammography database format to aid breast cancer diagnosis.
A logistic regression model based on the national mammography database format to aid breast cancer diagnosis.
复制标题
DOI:
10.2214/ajr.07.3345
复制
发表时间:
2009-04
期刊:
影响因子:
--
通讯作者:
Burnside ES
中科院分区:
文献类型:
--
作者:
Chhatwal J;Alagoz O;Lindstrom MJ;Kahn CE Jr;Shaffer KA;Burnside ES
To create a breast cancer risk estimation model based on the descriptors of National Mammography Database (NMD) format using logistic regression that can aid in decision-making for early detection of breast cancer. Institutional Review Board waived this HIPAA-compliant retrospective study from requiring informed consent. We created two logistic regression models based on the mammography features and demographic data for 62,219 consecutive cases of mammography records from 48,744 studies in 18,270 patients reported using the Breast Imaging-Reporting and Data System (BI-RADS) lexicon and NMD format between 4/5/1999 and 2/9/2004. State cancer registry outcomes matched with our data served as the reference standard. The probability of cancer was the outcome in both models. Model-2 was built using all variables in Model-1 plus radiologists’ BI-RADS assessment codes. We used 10-fold cross-validation to train and test the model and calculate the area under the receiver operating characteristic (ROC) curves (Az) to measure the performance. Both models were compared to the radiologists’ BI-RADS assessments. Radiologists achieved an Az value of 0.939 ± 0.011. The Az was 0.927 ± 0.015 for Model-1 and 0.963 ± 0.009 for Model-2. At 90% specificity, the sensitivity of Model-2 (90%) was significantly better (P<0.001) than that of radiologists (82%) and Model-1 (83%). At 85% sensitivity, the specificity of Model 2 (96%) was significantly better (P<0.001) than that of radiologists (88%) and Model-1 (87%). Our logistic regression model can effectively discriminate between benign and malignant breast disease and identify the most important features associated with breast cancer.